PTX
Click for more information
2.56% 4.0¢ prescient therapeutics limited

Would the incorporation of CellPryme-M into the manufacturing of...

  1. reon1
    1,382 Posts.
    lightbulb Created with Sketch. 443
    clock Created with Sketch.
    11/06/22
    13:52
    Post #: 61956808
    Would the incorporation of CellPryme-M into the manufacturing of an already approved (or clinically advanced) cell therapy product send that product back to phase 1 clinical trials?

    If so, CellPryme-M may only be attractive to pre-clinical or phase 1 assets.

    Anyone able to answer this question? If not, I'll email the company.
    PTX Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
EMD Emyria's Empax Centre chosen for mental health clinical trial
right-arrow Created with Sketch.
GT1 Green Technology hands the helm to Henry
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢ 		Change
0.001(2.56%) 		Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 3.9¢ $18.21K 455.2K

Buyers (Bids)

No. Vol. Price($)
2 95694 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 622328 4
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.